AlphaCentric Advisors’s BELLUS Health Inc. BLU Stock Holding History

AlphaCentric Advisors’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,600	Closed	-$37K	–	179
2020 Q2	$37K	Buy	+3,600	New	+$36.5K	0.02%	98

Other funds holding BLU

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

AlphaCentric Advisors's BLU Position: Q3 2020 in Review

AlphaCentric Advisors sold out of BELLUS Health Inc. (BLU) in Q3 2020, closing a stake of 3,600 shares — an estimated $37K sold.

AlphaCentric Advisors first reported a position in BLU in Q2 2020 and held it in 1 quarter. The position peaked at $37K in Q2 2020. 50 funds tracked by Wall St. Rank hold BLU as of Q3 2020.

AlphaCentric Advisors reported no remaining BELLUS Health Inc. position as of Q3 2020 after selling out during the quarter.
AlphaCentric Advisors sold 3,600 BELLUS Health Inc. shares in Q3 2020, an estimated $37K.
AlphaCentric Advisors first reported a position in BELLUS Health Inc. in Q2 2020 and held it in 1 quarter.
AlphaCentric Advisors's BELLUS Health Inc. position peaked at $37K in Q2 2020.
50 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2020.

Based on AlphaCentric Advisors's 13F filing for Q3 2020, filed 11 Mar 2022.